TRAF5 and neoplasm: M2-tumor-associated macrophages promote METTL3 expression and increase the m6A RNA content of TNF receptor-associated factor 5 (TRAF5), affecting the tumor microenvironment, promoting necroptosis, and leading to acquired oxaliplatin tolerance.116